kenji momo - Academia.edu (original) (raw)
Uploads
Papers by kenji momo
Journal of Pharmaceutical Health Care and Sciences, Aug 18, 2020
Journal of the Pharmaceutical Society of Japan, May 1, 2005
The Journal of Clinical Pharmacology, Mar 1, 2010
The Pharmaceutical Society of Japan, Feb 1, 2021
Biomedical Chromatography, Sep 15, 2022
Recently, global health concerns regarding increasing multidrug resistance have arisen. This stud... more Recently, global health concerns regarding increasing multidrug resistance have arisen. This study aimed to develop a simple, inexpensive and rapid high‐performance liquid chromatography–ultraviolet (HPLC–UV) method for determining urinary concentrations of a first‐generation cephem antibiotic in pediatric patients with urinary tract infections (UTIs). HPLC–UV was used to analyze urinary cefazolin concentrations at a detection wavelength of 254 nm. The assay used contained 10‐fold diluted urine with an internal standard (cephapirin). The standard calibration curve for cefazolin was linear in the concentration range of 31.25–500 μg/ml (r2 > 0.999). The retention times of cefazolin and the internal standard were 4.2 and 4.9 min, respectively. The within‐ and between‐day coefficients of variation were in the concentration ranges 1.2–15.2 and 5.5–19.2%, respectively. The urinary cefazolin concentration of a pediatric patient with a UTI was 1,476.6 μg/ml, which was over 700‐fold higher than the minimum inhibitory concentration of cefazolin (≤2 μg/ml). The developed method is applicable to the confirmation of appropriate use for UTI treatment as therapeutic drug monitoring of cefazolin. Therefore, the findings of this study may contribute to the appropriate use of antibiotics to prevent antimicrobial resistance in pediatric patients with UTIs.
Biological & Pharmaceutical Bulletin, Sep 1, 2022
Clinical Nephrology, Jun 1, 2019
Journal of Clinical Pharmacy and Therapeutics, May 6, 2019
Journal of the Pharmaceutical Society of Japan, 2013
Journal of Orthopaedic Science, Feb 1, 2023
Biomedical Chromatography, Mar 4, 2011
Journal of Infection and Chemotherapy, Feb 1, 2023
Biological & Pharmaceutical Bulletin, Oct 1, 2022
Journal of the Pharmaceutical Society of Japan, Feb 1, 2021
Japanese Journal of Pharmaceutical Health Care and Sciences, Nov 10, 2018
Japanese Journal of Pharmaceutical Health Care and Sciences, Nov 10, 2018
International Journal of Clinical Pharmacology and Therapeutics, Dec 1, 2013
Our aim was to determine whether metabolic clearance, renal clearance, or both elimination pathwa... more Our aim was to determine whether metabolic clearance, renal clearance, or both elimination pathways contribute to ethnic differences in tizanidine clearance, which is ~ 2-fold higher in Caucasians than in Asians. The pharmacokinetic parameters of tizanidine in 9 healthy male Japanese subjects were compared with those of Caucasians in previous studies. Metabolic clearance of tizanidine was lower in Japanese than in Caucasian subjects (5.9 vs. 8.1 - 10.9 l/h/kg), although renal clearances were similar (0.040 vs. 0.047 - 0.055 l/h/kg). The results suggest that ethnic differences in tizanidine clearance are due to differences in metabolic clearance.
Journal of Palliative Medicine, Aug 1, 2020
Palliative Care Research, 2007
Journal of Pharmaceutical Health Care and Sciences, Aug 18, 2020
Journal of the Pharmaceutical Society of Japan, May 1, 2005
The Journal of Clinical Pharmacology, Mar 1, 2010
The Pharmaceutical Society of Japan, Feb 1, 2021
Biomedical Chromatography, Sep 15, 2022
Recently, global health concerns regarding increasing multidrug resistance have arisen. This stud... more Recently, global health concerns regarding increasing multidrug resistance have arisen. This study aimed to develop a simple, inexpensive and rapid high‐performance liquid chromatography–ultraviolet (HPLC–UV) method for determining urinary concentrations of a first‐generation cephem antibiotic in pediatric patients with urinary tract infections (UTIs). HPLC–UV was used to analyze urinary cefazolin concentrations at a detection wavelength of 254 nm. The assay used contained 10‐fold diluted urine with an internal standard (cephapirin). The standard calibration curve for cefazolin was linear in the concentration range of 31.25–500 μg/ml (r2 > 0.999). The retention times of cefazolin and the internal standard were 4.2 and 4.9 min, respectively. The within‐ and between‐day coefficients of variation were in the concentration ranges 1.2–15.2 and 5.5–19.2%, respectively. The urinary cefazolin concentration of a pediatric patient with a UTI was 1,476.6 μg/ml, which was over 700‐fold higher than the minimum inhibitory concentration of cefazolin (≤2 μg/ml). The developed method is applicable to the confirmation of appropriate use for UTI treatment as therapeutic drug monitoring of cefazolin. Therefore, the findings of this study may contribute to the appropriate use of antibiotics to prevent antimicrobial resistance in pediatric patients with UTIs.
Biological & Pharmaceutical Bulletin, Sep 1, 2022
Clinical Nephrology, Jun 1, 2019
Journal of Clinical Pharmacy and Therapeutics, May 6, 2019
Journal of the Pharmaceutical Society of Japan, 2013
Journal of Orthopaedic Science, Feb 1, 2023
Biomedical Chromatography, Mar 4, 2011
Journal of Infection and Chemotherapy, Feb 1, 2023
Biological & Pharmaceutical Bulletin, Oct 1, 2022
Journal of the Pharmaceutical Society of Japan, Feb 1, 2021
Japanese Journal of Pharmaceutical Health Care and Sciences, Nov 10, 2018
Japanese Journal of Pharmaceutical Health Care and Sciences, Nov 10, 2018
International Journal of Clinical Pharmacology and Therapeutics, Dec 1, 2013
Our aim was to determine whether metabolic clearance, renal clearance, or both elimination pathwa... more Our aim was to determine whether metabolic clearance, renal clearance, or both elimination pathways contribute to ethnic differences in tizanidine clearance, which is ~ 2-fold higher in Caucasians than in Asians. The pharmacokinetic parameters of tizanidine in 9 healthy male Japanese subjects were compared with those of Caucasians in previous studies. Metabolic clearance of tizanidine was lower in Japanese than in Caucasian subjects (5.9 vs. 8.1 - 10.9 l/h/kg), although renal clearances were similar (0.040 vs. 0.047 - 0.055 l/h/kg). The results suggest that ethnic differences in tizanidine clearance are due to differences in metabolic clearance.
Journal of Palliative Medicine, Aug 1, 2020
Palliative Care Research, 2007